Deletion of 18q is a strong and independent prognostic feature in prostate cancer-Reference-Cited by-同舟云学术

Deletion of 18q is a strong and independent prognostic feature in prostate cancer

Published:2016-11-16 Issue:52 Volume:7 Page:86339-86349
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Kluth Martina¹,Graunke Maximilian¹,Möller-Koop Christina¹,Hube-Magg Claudia¹,Minner Sarah¹,Michl Uwe²,Graefen Markus²,Huland Hartwig²,Pompe Raisa²,Jacobsen Frank¹,Hinsch Andrea¹,Wittmer Corinna¹,Lebok Patrick¹,Steurer Stefan¹,Büscheck Franziska¹,Clauditz Till¹,Wilczak Waldemar¹,Sauter Guido¹,Schlomm Thorsten²³,Simon Ronald¹

Affiliation:

1. Institute of Pathology, Prostate Cancer Center at University Medical Center Hamburg-Eppendorf, Germany

2. Martini-Clinic, Prostate Cancer Center at University Medical Center Hamburg-Eppendorf, Germany

3. Department of Urology, Section for prostate cancer research, University Medical Center Hamburg-Eppendorf, Germany

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Safety Issues Related to Pluripotent Stem Cell-Based Therapies: Tumour Risk;Pluripotent Stem Cell Therapy for Diabetes;2023

2. Reduced anoctamin 7 (ANO7) expression is a strong and independent predictor of poor prognosis in prostate cancer;Cancer Biology and Medicine;2021

3. Epithelial splicing regulatory protein 1 and 2 (ESRP1 and ESRP2) upregulation predicts poor prognosis in prostate cancer;BMC Cancer;2020-12

4. A copy number gain on 18q present in primary prostate tumors is associated with metastatic outcome;Urologic Oncology: Seminars and Original Investigations;2020-12

5. Increased Cytoplasmic CD138 Expression Is Associated with Aggressive Characteristics in Prostate Cancer and Is an Independent Predictor for Biochemical Recurrence;BioMed Research International;2020-10-28